Aug 8 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 18 mln 231 mln 122 mln
(-91.9 pct) (-52.5 pct)
Operating loss 609 mln loss 135 mln loss 1.34
Recurring loss 623 mln loss 84 mln loss 1.34
Net loss 629 mln loss 61 mln loss 1.35
EPS loss 12.82 yen loss 1.51 yen loss 25.24 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T